Search

Copyright © Author(s) (or their employer(s)) 2022. Introduction: We have previously reported the initial clinical and imaging findings of a woman with a novel MAPT Q351R mutation.1 2 We continued to assess her following these case reports until she died and have now analysed her brain at postmortem. Her case was of unique interest due to the novelty of the mutation and its clinical features1 as well as the strong binding seen on flortaucipir positron emission tomography (PET) imaging,2 which was suggestive of a very specific pathological finding, that of a mixed 3R/4R tauopathy, similar to that seen in other MAPT mutations (V337M and R406W),3 4 and consistent with the same type of paired helical filament tau pathology seen in Alzheimer’s disease (AD). She is the first patient with this mutation to come to autopsy and we report the findings in this study. Methods: A patient with a Q351R mutation was seen over a 20-year period, during which time she was assessed clinically, and with repeated MR brain imaging (11 scans in total) as well as flortaucipir PET imaging. In this report, her MR imaging is compared against a cohort of 43 healthy individuals (all women; mean age 61.5 years old, range 49.7–68.5 years old). All participants gave their consent to take part. At the time of death, her brain was donated to the Queen Square Brain Bank for Neurological Disorders and underwent postmortem analysis. Results: Clinical history She presented to a specialist cognitive neurology clinic in her late 40s with a 4-year history of amnestic symptoms and mild behavioural change, mainly in the form of apathy. Neurological examination was normal, but her initial neuropsychological assessment showed the presence of episodic and semantic memory impairment with other cognitive domains intact.1 Following this, there was a slow progression of cognitive and behavioural symptoms over the next 20 years, with increasing forgetfulness and apathy, as well as prominent disinhibition, change in appetite and musicophilia. In addition, 13 years into her illness, she developed parkinsonism with bradykinesia, rigidity and both resting and postural tremor. She was still living at home and was able to attend research appointments until her mid 60s. She died in her late 60s, 24 years into her illness. Brain imaging: MR imaging throughout the course of her illness showed slowly progressive atrophy with a whole brain atrophy rate over the whole course of the illness of 0.7% per year (figure 1A). The pattern of involvement was initially dominated by focal medial temporal atrophy affecting the amygdala and anterior more than posterior hippocampus. Over time, there was progressive cortical involvement also, affecting the temporal and insular cortices and later the frontal and anterior cingulate cortices. Striatal atrophy, particularly ventrally, was seen later in the condition as well (figure 1B,C). In contrast, posterior cortical regions were relatively spared. Flortaucipir PET imaging showed strong binding of the tracer2 similar to that seen in both AD and a small subgroup of MAPT mutations (R406W and V337M) (figure 1D). Alzheimer's Research UK; Alzheimer's Society; Brain Research UK; The Wolfson Foundation; UK DRI Ltd, funded by the UK Medical Research Council, Alzheimer's Society and Alzheimer's Research UK; Miriam Marks Brain Research UK Senior Fellowship; MRC Clinician Scientist Fellowship (MR/M008525/1); NIHR Rare Disease Translational Research Collaboration (BRC149/NS/MH); Alzheimer’s Society and by the NIHR UCLH Biomedical Research Centre; NIHR UCL/H Biomedical Research Centre; UK Dementia Research Institute which receives its funding from DRI Ltd, funded by the UK Medical Research Council, Alzheimer’s Society and Alzheimer’s Research UK.

Pathogens evade host humoral responses by accumulating mutations in surface antigens. While variable, there are conserved regions that cannot mutate without compromising fitness. Antibodies targeting these conserved epitopes are often broadly protective but remain minor components of the repertoire. Rational immunogen design leverages a structural understanding of viral antigens to modulate humoral responses to favor these responses. Here, we report an epitope-enriched immunogen presenting a higher copy number of the influenza hemagglutinin (HA) receptor-binding site (RBS) epitope relative to other B cell epitopes. Immunization in a partially humanized murine model imprinted with an H1 influenza shows H1-specific serum and99% H1-specific B cells being RBS-directed. Single B cell analyses show a genetically restricted response that structural analysis defines as RBS-directed antibodies engaging the RBS with germline-encoded contacts. These data show how epitope enrichment expands B cell responses toward conserved epitopes and advances immunogen design approaches for next-generation viral vaccines.

Genetic variants have been associated with myriad molecular phenotypes that provide new insight into the range of mechanisms underlying genetic traits and diseases. Identifying any particular genetic variant's cascade of effects, from molecule to individual, requires assaying multiple layers of molecular complexity. We introduce the Enhancing GTEx (eGTEx) project that extends the GTEx project to combine gene expression with additional intermediate molecular measurements on the same tissues to provide a resource for studying how genetic differences cascade through molecular phenotypes to impact human health.

Ten percent of head injuries quality as "severe," requiring prompt diagnosis and treatment. This level I trauma center uses an aggressive approach to treatment of severe head injuries and, when indicated, intervenes with decompressive craniectomy. This article explains decompressive craniectomy, including indications, procedures, and protocols. The case studies presented highlight two patients with profound head injuries. Additionally, cranioplasty replacement of autograft flap is explained and discussed.

In recent years, many new designs of micro robots have been developed. Miniaturization is a challenge and most mechanisms designed up to now are not autonomous, i.e. they don't have their intelligence and/or power supply on board. A new fully autonomous miniature mobile robot has been designed in our lab in a final year project. It has been programmed to follow a black line printed on the ground. An autonomous mechatronic system consists at least of a sensor, an actuator, a microprocessor to provide intelligence and a power supply. In our case, the robot's intelligence is based on a PIC16C71 microcontroller that controls its movement. To follow a black line, an infrared emitter and two receivers are placed at the front of the robot. As actuators, two watch motors are used. The gears of the watch's second hand are directly used as wheels to move the system. Two small batteries supply the energy to the motors and the microprocessor as well. The technical details of the mini mobile robot are as follows: dimensions: 20 mm * 8 mm * 15 mm; velocity: 40 mm/s; power consumption: 6 mW. This low power consumption allows the system to move autonomous for about 8 - 10 hours.© (1995) COPYRIGHT SPIE--The International Society for Optical Engineering. Downloading of the abstract is permitted for personal use only.